Grant Details

GRANT OVERVIEW

Grant name and funding organization

NHLBI Program Project Applications (P01 Clinical Trials Optional)

National Institutes of Health (NIH)

Total funding amount and duration

Maximum project period is 5 years.

Budget requests are limited to $1,515,000 in direct costs per year, or $1,765,000 if an ESI-led project is included.

Primary objective and mission statement

Support research related to heart, lung, blood, and sleep disorders.

Encourage collaborative research through interrelated projects.

Key stakeholders and beneficiaries

Researchers in the fields of heart, lung, blood, and sleep disorders.

Institutions and organizations involved in biomedical research.

ELIGIBILITY CRITERIA

Organization Requirements

Eligible organizations include higher education institutions, nonprofits, for-profit organizations, local and state governments, and tribal governments.

Non-domestic (non-U.S.) entities are not eligible to apply, but non-domestic components of U.S. organizations can apply.

Geographic Scope

Organizations must be based in the U.S. or have U.S. components.

Project Requirements

Applications must include at least three interrelated research projects.

Projects should address a common central theme within the NHLBI's mission.

Financial Requirements

Direct costs are capped at $1,515,000 per year, or $1,765,000 if including an ESI-led project.

No cost-sharing is required.

Timeline Requirements

Application due dates include January 25, 2024, and subsequent dates every few months until September 25, 2026.

Applications are due by 5:00 PM local time of the applicant organization.

Previous Funding Considerations

No more than half of the projects in a funded application may overlap with currently funded individual research project grants.

APPLICATION PROCESS

Required documentation and materials

Applications must follow the Multi-Project Instructions in the How to Apply - Application Guide.

A letter of intent is encouraged but not required.

Evaluation criteria and scoring system

Applications will be evaluated based on scientific merit, innovation, approach, and integration of projects.

Review process and timeline

Applications undergo a two-step review process by a Tailored Review Committee and the Heart, Lung, and Blood Program Project Review Committee.

Selection criteria and priorities

Overall impact score will reflect the likelihood of the project to influence the research field.

SPECIAL CONSIDERATIONS

Unique aspects or requirements

Encouragement of new scientific directions and inclusion of Early Stage Investigators.

Potential challenges or limitations

Applications that do not comply with submission instructions may be delayed or rejected.

Strategic alignment opportunities

Collaboration among projects is essential for success.

Competitive advantages or disadvantages

Strong institutional support and previous experience in leading research projects are advantageous.

KEY INSIGHTS AND RECOMMENDATIONS

Critical success factors

Thematic integration among projects and strong leadership are crucial.

Common pitfalls to avoid

Avoid submitting overlapping applications or failing to meet compliance requirements.

Strategic recommendations for applicants

Engage with NHLBI staff early in the application process for guidance.

Competitive positioning advice

Highlight unique aspects of the proposed research and collaborative potential.

Grant Details

health biomedical research heart disease lung disease blood disorders sleep disorders clinical trials collaborative research early stage investigator
NHLBI Program Project Applications (P01 Clinical Trials Optional)
PAR-24-065
National Institutes of Health (NIH)
EDU NGO ENTERPRISE PUBLIC OTHER
US
RESEARCH_DEVELOPMENT
False
None
None
None
USD
None
True
True
Accelerate the acquisition of knowledge in heart, lung, blood, and sleep disorders through collaborative research.
At least three interrelated research projects addressing a common theme.
Sept. 25, 2026, 10 p.m.
March 2025 - July 2027
Multi-Project Instructions, letter of intent (optional).
True
Overall impact score based on scientific merit.
Novel approaches and methodologies in research.
Well-reasoned strategy and methodology.
Potential to influence the research field significantly.
False
False
Grant
Compliance with NIH Grants Policy Statement.
Annual progress reports and financial statements.
Details outlined in the NIH Grants Policy Statement.
NIH Grants Policy Statement applies.
None